PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-15

Date Title Company
15-Feb-2024 Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response Businesswire
15-Feb-2024 Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Lymphoma (AML) and High-Risk Myelodysplastic Syndromes (MDS) Businesswire
15-Feb-2024 Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology Businesswire
15-Feb-2024 Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) Businesswire
15-Feb-2024 Modular Medical Announces Proposed Public Offering AccessWire
15-Feb-2024 The American Academy of Stem Cell Physicians Recently Concluded Its Seventh Scientific Session in Miami AccessWire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of InMode Ltd. (INMD) on Behalf of Investors Businesswire
15-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Children's Place, Inc. (PLCE) on Behalf of Investors Businesswire
15-Feb-2024 Areteia Therapeutics gibt Ernennung von Daniel Becker, M.D., Ph.D. in Areteia Board of Directors bekannt Businesswire
15-Feb-2024 Global Actuators Strategic Industry Report 2024: Reach $108.7 Billion by 2030 - Smart Cities Emerge as Major Opportunity - ResearchAndMarkets.com Businesswire
15-Feb-2024 MedinCell to Present at the Evercore ISI 2024 Emerging Biotech Conference Businesswire
15-Feb-2024 BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering AccessWire
15-Feb-2024 Areteia Therapeutics annonce la nomination de Daniel Becker, M.D., Ph.D. au conseil d'administration Businesswire
15-Feb-2024 Grand Opening of Coastal Vision Medical Group's Advanced Office in Orange, CA AccessWire
15-Feb-2024 INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Businesswire
15-Feb-2024 INDM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Businesswire
15-Feb-2024 eClinical Solutions Highlights Notable Year of Growth Supporting Biopharma's Complex Data Demands Businesswire
15-Feb-2024 Simulations Plus Extends Collaboration with Major Toxicology Research Agency Businesswire
15-Feb-2024 Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers Businesswire
15-Feb-2024 Kyriba’s Quarterly Currency Impact Report: Currency Impact Reported by North American and European Companies Totaled $30 Billion Businesswire